SNHG7 also causes arrest in the G1/G0 phase of the cell cycle (Wang et al., 2017a; Xu et al., 2018); regulates signaling pathways, such as Wnt/β-Catenin and AKT/mTOR pathways; and represses tumor suppressors, such as P15 and P16 (Wang et al., 2017b; Li et al., 2020b; Chi et al., 2020; Du et al., 2020). The gene discussed is SNHG7; the disease is neoplasm.